166 related articles for article (PubMed ID: 34124253)
1. Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer.
Liu S; He L; Sheng C; Su R; Wu X; Sun Y; Xi X
Biomed Res Int; 2021; 2021():6622439. PubMed ID: 34124253
[TBL] [Abstract][Full Text] [Related]
2. RIPK4 Promotes Cell Invasion and the Epithelial-Mesenchymal Transition in Ovarian Cancer.
Hua L; Wu JH; Xu JY; Wu SG; Zhou J
Front Biosci (Landmark Ed); 2023 Dec; 28(12):368. PubMed ID: 38179758
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6.
Yi H; Su YZ; Lin R; Zheng XQ; Pan D; Lin DM; Gao X; Zhang R
J Immunol Res; 2021; 2021():8875450. PubMed ID: 33855091
[TBL] [Abstract][Full Text] [Related]
4. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
Jin A; Zhang L; Fang G; Chen Y
Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
[TBL] [Abstract][Full Text] [Related]
5. RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer.
Liao C; Zhao YX; Han WD; Lai NY
J Immunol Res; 2022; 2022():7599098. PubMed ID: 35310605
[TBL] [Abstract][Full Text] [Related]
6. Silencing of RIPK4 inhibits epithelial‑mesenchymal transition by inactivating the Wnt/β‑catenin signaling pathway in osteosarcoma.
Yi Z; Pu Y; Gou R; Chen Y; Ren X; Liu W; Dong P
Mol Med Rep; 2020 Mar; 21(3):1154-1162. PubMed ID: 32016450
[TBL] [Abstract][Full Text] [Related]
7. Increased RIPK4 expression is associated with progression and poor prognosis in cervical squamous cell carcinoma patients.
Liu DQ; Li FF; Zhang JB; Zhou TJ; Xue WQ; Zheng XH; Chen YB; Liao XY; Zhang L; Zhang SD; Hu YZ; Jia WH
Sci Rep; 2015 Jul; 5():11955. PubMed ID: 26148476
[TBL] [Abstract][Full Text] [Related]
8. KDF1 Promoted Proliferation and Metastasis of Epithelial Ovarian Cancer
Zhu C; Liu Y; Tong R; Guan J
Front Genet; 2022; 13():808100. PubMed ID: 35281796
[No Abstract] [Full Text] [Related]
9. Decreased expression of TFAP2B in endometrial cancer predicts poor prognosis: A study based on TCGA data.
Wu H; Zhang J
Gynecol Oncol; 2018 Jun; 149(3):592-597. PubMed ID: 29602546
[TBL] [Abstract][Full Text] [Related]
10. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
Chen H; Tian X; Luan Y; Lu H
Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
[TBL] [Abstract][Full Text] [Related]
11. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
[TBL] [Abstract][Full Text] [Related]
12. [Association between RIPK4 relative copy number and prognosis of colorectal cancer patient after oxaliplatin-based chemotherapy].
Peng K; Lin M; Wei Q; Li H; Zhang C; Xie R; Liu Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1111-4. PubMed ID: 26616804
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of PKMYT1 Facilitates Tumor Development and Is Correlated with Poor Prognosis in Clear Cell Renal Cell Carcinoma.
Chen P; Zhang Z; Chen X
Med Sci Monit; 2020 Oct; 26():e926755. PubMed ID: 33024069
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of LYNX1 in Ovarian Serous Cystadenocarcinoma Predicts Poor Prognosis.
Liu H; Wang A; Ma Y
Biomed Res Int; 2020; 2020():1392674. PubMed ID: 33299855
[TBL] [Abstract][Full Text] [Related]
15. SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis.
Yang M; Xie X; Ding Y
Oncol Rep; 2016 Mar; 35(3):1796-806. PubMed ID: 26750614
[TBL] [Abstract][Full Text] [Related]
16. Decreased SPTLC1 expression predicts worse outcomes in ccRCC patients.
Zhu WK; Xu WH; Wang J; Huang YQ; Abudurexiti M; Qu YY; Zhu YP; Zhang HL; Ye DW
J Cell Biochem; 2020 Feb; 121(2):1552-1562. PubMed ID: 31512789
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma.
Wang J; Xiao L; Luo CH; Zhou H; Hu J; Tang YX; Fang KN; Zhang Y
Asian Pac J Cancer Prev; 2014; 15(9):3955-8. PubMed ID: 24935580
[TBL] [Abstract][Full Text] [Related]
18. Targeting eukaryotic elongation factor-2 kinase suppresses the growth and peritoneal metastasis of ovarian cancer.
Erdogan MA; Ashour A; Yuca E; Gorgulu K; Ozpolat B
Cell Signal; 2021 May; 81():109938. PubMed ID: 33539938
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of SPINK13 Promotes Metastasis by Regulating uPA in Ovarian Cancer Cells.
Cai S; Zhang P; Dong S; Li L; Cai J; Xu M
Cell Physiol Biochem; 2018; 45(3):1061-1071. PubMed ID: 29439245
[TBL] [Abstract][Full Text] [Related]
20. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway.
Yu G; Wang W; Deng J; Dong S
Mol Med Rep; 2019 May; 19(5):3615-3621. PubMed ID: 30896797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
